BlogDividends

Dividends

Novo Nordisk: 60% Upside Potential for this Dividend Growth Giant

Novo Nordisk: 60% Upside Potential for this Dividend Growth Giant

Key Takeaways: After a sharp selloff, Novo Nordisk is starting to look like an attractive opportunity for long-term investors. The industry leader now offers its highest dividend yield in five years, while its core pharmaceutical business in diabetes and obesity treatments continues to drive solid growth. With analysts projecting that the stock could have 63% …

Merck Stock: Undervalued High-Yield Healthcare Stock

Merck Stock: Undervalued High-Yield Healthcare Stock

Key Takeaways: Merck is a mature company with a well-established track record, a healthy balance sheet, and a commitment to rewarding shareholders. With a 3.9% dividend yield, consistent earnings growth driven by its strong pharmaceutical portfolio, and analysts projecting 35% upside, Merck is starting to look like an attractive option for long-term investors. With the …

ASML Stock: Near-Monopoly Business with Dividend Growth Potential

ASML Stock: Near-Monopoly Business with Dividend Growth Potential

Key Takeaways: ASML (ASML) holds a near monopoly in the semiconductor industry with its hold on the extreme ultraviolet lithography (EUV) machines market. This is one of the key technologies needed to produce the world’s most advanced chips. The company has been quietly returning billions to shareholders through share buybacks and dividends while continuing to …

Join thousands of investors worldwide who use TIKR to supercharge their investment analysis.

Sign Up for FREENo credit card required